Novel therapeutics from modern biotechnology : from laboratory to human testing /
This volume addresses the particular problems associated with several classes of biotechnology products, and at the same time demonstrates that the principles are the same as in the development of small new chemical entities. The first chapter addresses FDA regulatory expectations for biotech produc...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin ; New York :
Springer,
[1999]
|
| Edition: | Springer study ed. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | This volume addresses the particular problems associated with several classes of biotechnology products, and at the same time demonstrates that the principles are the same as in the development of small new chemical entities. The first chapter addresses FDA regulatory expectations for biotech products. The next several chapters discuss general issues common to each class of biotech drug such as proteins, peptides, and nucleic acids. The balance of the chapters deal with specific biotech drugs that have successfully made it into clinical trials. The reviews are written by renowned experts in their fields. |
|---|---|
| Item Description: | "Second printing 1999 (Originally published in the Handbook of experimental pharmacology, volume 137, ISBN 3540650253, 1999)." Electronic resource. |
| Physical Description: | 1 online resource (xvii, 248 pages) : illustrations |
| Format: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 9783642599903 (electronic bk.) 3642599907 (electronic bk.) |